CG Oncology Reports on Shareholder Vote Matters

Ticker: CGON · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1991792

Cg Oncology, Inc. 8-K Filing Summary
FieldDetail
CompanyCg Oncology, Inc. (CGON)
Form Type8-K
Filed DateJun 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-meeting

TL;DR

CG Oncology held a shareholder vote on June 5th.

AI Summary

CG Oncology, Inc. filed an 8-K on June 6, 2025, reporting on a submission of matters to a vote of security holders that occurred on June 5, 2025. The company, incorporated in Delaware with its principal executive offices in Irvine, California, is in the biological products sector.

Why It Matters

This filing indicates that CG Oncology, Inc. has held or is holding a vote of its security holders, which is a standard corporate governance event that can impact company direction.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting a shareholder vote, with no immediate financial or operational risks disclosed.

Key Players & Entities

  • CG Oncology, Inc. (company) — Registrant
  • June 05, 2025 (date) — Date of earliest event reported
  • June 06, 2025 (date) — Date of Report
  • Delaware (jurisdiction) — State of Incorporation
  • Irvine, California (location) — Principal Executive Offices
  • 001-41925 (other) — Commission File Number
  • 37-1611499 (other) — IRS Employer Identification No.

FAQ

What specific matters were submitted to a vote of CG Oncology, Inc. security holders?

The filing states that matters were submitted to a vote of security holders, but does not specify the exact nature of these matters in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 05, 2025.

What is the Commission File Number for CG Oncology, Inc.?

The Commission File Number for CG Oncology, Inc. is 001-41925.

Where are CG Oncology, Inc.'s principal executive offices located?

CG Oncology, Inc.'s principal executive offices are located at 400 Spectrum Center Drive, Suite 2040, Irvine, California, 92618.

What is the Standard Industrial Classification code for CG Oncology, Inc.?

The Standard Industrial Classification code for CG Oncology, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding CG Oncology, Inc. (CGON).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.